外体 miR-93-3p 针对 EIF4EBP1 调节巨分化并加速门瘤手术后的伤口愈合
Wei Zhang1, Wenzhe Feng2, Junhong Chen1
1First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, China.
Frontiers in pharmacology
|September 3, 2025
概括
这项研究确定外体 miR-93-3p 是管瘤手术后巨细胞分化调节的关键. 它展示了这种微RNA如何通过EIF4EBP1轴促进抗炎反应,支持基于外体的新疗法.
科学领域:
- 分子生物学
- 免疫学
- 复原医学
背景情况:
- 经过囊 (AF) 手术后的伤口愈合延迟是一个重大的临床挑战.
- 确定术后炎症的调节机制对于改善患者的治疗结果至关重要.
- 外体微RNA (miRNA) 参与细胞间通信和组织修复.
研究的目的:
- 确定和验证AF手术后调节术后炎症的关键外体miRNA.
- 阐明这些miRNAs影响巨细胞M1/M2极化的分子机制.
- 研究外体miR-93-3p/EIF4EBP1轴在促进抗炎反应中的作用.
主要方法:
- 多组分析 (miRNA微阵列,qPCR) 和功能测试的整合.
- 从接受AF手术的患者的伤口排泄物中分离出外体.
- 使用THP-1衍生的巨细胞,生物信息学预测 (TargetScan,GO,KEGG) 和双露西法酶报告测试的体外研究.
主要成果:
- 鉴定出外体miR-93-3p是显著差异表达的miRNA.
- 通过降低M1标志物 (CD86) 和上调M2标志物 (Arg-1,CD206),miR-93-3p的过度表达促进了M2巨分化.
- 通过调节炎症反应,miR- 93- 3p可以直接向和抑制EIF4EBP1的表达.
结论:
- 这项研究阐明了传统中医 (TCM) 方法Euriching Pus for Tissue Growth的分子机制,通过外体miR-93-3p/EIF4EBP1轴促进M2巨分化.
- 这一发现为开发基于外体的新型miRNA治疗策略提供了理论基础,用于AF手术后的抗炎治疗.
- 外体 miR-93-3p 是AF手术后增强伤口愈合的潜在治疗点.
更多相关视频
09:06Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.
Published on: March 25, 2020
8.8K
08:58Using R, Seurat, and CellChat to Analyze a Single-Cell Transcriptomics Dataset of Mouse Skin Wound Healing
Published on: August 1, 2025
488
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
